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Ectopic pregnancies are situated outside the normal 
endometrial lining of the uterus. These conceptuses 
are also regarded as extrauterine pregnancies. This 
may not be strictly correct however, as pregnancies 
located in the interstitial, cornual and cervical 
portions of the uterus, though ectopic, are still 
regarded as uterine in location.
Varying incidences for ectopic pregnancies have 
been quoted. These figures are sometimes difficult 
to reconcile because different denominators have 
been employed in the calculations e.g. the figures 
from Lithuania are 23.8/1000 live births, 
11.2/reported 1000 pregnancies and 10.1/10,000 
women aged 15-44 years! However, a review of the 
trend suggests that the overall incidence is 
increasing due to the development of highly-
sensitive pregnancy detection kits (able to identify 
cases that would otherwise have spontaneously 
resolved) and transvaginal ultrasound imaging 
techniques.
Cervical pregnancy refers to an uncommon form of 
ectopic pregnancy implanted within the cervical 
mucosa. It is estimated that 0.15 % (< 1%) of all 
ectopic pregnancies are cervical pregnancies, and 
, , 
they make up about 1 in 18000 deliveries.
Ectopic pregnancy was the cause of eight of the 129 
direct maternal deaths in the United Kingdom (1994 
- 96) and is an important cause of maternal mortality 
in the first trimester. Also cervical pregnancies 
could result into life-threatening haemorrhage, 
4 requiring hysterectomy in about 50% of cases.
Thus, a high index of suspicion, close surveillance 
of at-risk patients and a knowledge of the evidence-
based management options of this rare pregnancy 
complication will reduce its case fatality rate.
The use of sensitive kits for the detection of beta-
human chorionic gonadotrophin levels and high-
resolution ultrasonography has resulted into earlier 
diagnosis, thus shifting the management from 
inpatient surgical therapy to selective outpatient 
management. 
This review will highlight the diagnostic clues and 
also discuss the various modalities of management 
of cervical ectopic pregnancies and the outcome 
from the available literature.
  
MATERIALS AND METHODS
An electronic search of the published literature was 
conducted using the search terms “cervical 
p r e g n a n c y, ”  “ e c t o p i c  p r e g n a n c y ”  a n d  
“management.” Pub Med, and other indexed 
journals specifically addressing management of 
cervical ectopics were searched. An Internet Google 
search with the terms “pregnancy/ectopic/cervix” 
was also done. Websites of international 
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ABSTRACT 
Ectopic pregnancy is associated with significant morbidity and mortality in the first trimester. With in vitro 
fertilization and better early diagnosis, the incidence of ectopic pregnancies has increased. Although cervical 
pregnancies are <1% of all ectopic pregnancies, they could be associated with life-threatening bleeding. Transvaginal 
ultrasonography is the mainstay of diagnosis of cervical pregnancy, but beta-human chorionic gonadotrophin may be 
helpful in monitoring treatment outcomes. Current therapeutic options for cervical pregnancies include conservative 
management which could be medical, surgical or both, and 'radical' surgery.  
The advent of real-time transvaginal ultrasound examination has allowed earlier diagnosis which has in turn 
permitted life-saving and fertility-sparing treatment options. Various conservative haemostatic measures may be 
used if bleeding occurs during conservative management. Clinicians should watch carefully for a possible increased 
risk of preterm labour or incompetent cervix, while reassuring patients that most pregnancies after a cervical ectopic 
will lead to term deliveries.
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organizations and private foundations with a 
bearing on the topic were also searched. All original 
articles that addressed various management options 
of cervical ectopic pregnancy and their outcomes 
were included in the study. The search was restricted 
to English language articles.
RESULTS
Historical background
Before 1970, the diagnosis of cervical pregnancy 
was commonly made when dilatation and curettage 
for presumed incomplete abortion resulted in 
unexpected haemorrhage. The use of cervical 
imaging techniques has however made earlier 
diagnosis with more certainty possible. This was 
initially done transabdominally, making the 
diagnosis obvious before the onset of severe 
,  , 
haemorrhage, and later transvaginally.   Recently, 
magnetic resonance imaging of cervical 
, 
pregnancies has also been documented.
Traditionally, due to delayed diagnosis, 
hysterectomy used to be the only life-saving option. 
However with earlier diagnosis, non-surgical 
methods e.g. local or systemic methotrexate 
, 
administration have been successfully used.  The 
use of methotrexate in the treatment of cervical 
ectopic was first reported by Farabow et al in 1983, 
and this has been followed by other documented 
13, 14cases.  Surgical evacuation of products of 
5conception with subsequent cervical cerclage,  local 
sonographically-guided potassium chloride 
injection or prostaglandin instillation and the use of 
9, 16a Foley catheter  to prevent severe haemorrhage 
have also been documented.
Tamponade of the bleeding implantation bed in the 
cervix using the inflated balloon of a Foley catheter 
was first documented by Kuppuswami et al. 
Subsequently, reports employing balloon 
tamponade alone or in conjunction with other 
, 
measures were documented.      
Aetiology and Risk Factors
The aetiology is obscure, although accelerated 
migration of the fertilized ovum through the uterus 
(such that there is rapid transportation of the 
fertilized ovum to the cervical canal before it is 
capable of nidation), damage to the endocervical 
canal and in vitro fertilization have all been 
4, 9, postulated as possible mechanisms.
Thus, the risk factors include previous dilatation and 
13curettage, previous cervical pregnancy  or uterine 
scar, pelvic inflammatory disease and endocervical 
inflammation from intrauterine contraceptive 
4, 9, 26
device.  Other risk factors include multifetal 
pregnancy, embryonic chromosomal anomalies, 
tumours of the reproductive tract and decidual 
proliferation of the endocervical epithelium due to 
hyperoestrogenaemia.
Cervical ectopics have been documented after in-
vitro fertilization and embryo transfer and even after 
intra-fallopian transfer, suggesting that the 
incidence of cervical pregnancies increase with 
increasing use of assisted reproductive 
3 technologies. However, a study by Kirk et al 
including seven cases of cervical pregnancies 
showed that all the ectopics were products of 
spontaneous conceptions. It is yet to be decided 
therefore, whether these risk factors are more of 
postulations than proofs.
Clinical Presentation
The clinical presentation is usually that of painless 
first-trimester vaginal bleeding after a variable 
period of amenorrhoea, although cramps have been 
described by some patients. Pelvic examination 
could reveal a bluish cervical lesion, soft but 
enlarged cervix (sometimes disproportionately so in 
comparison with the uterus), a partially dilated 
cervical os and profuse haemorrhage on 
10manipulating the cervix.
Diagnosis
Using trans-vaginal ultrasonography, Timor-Tritsch 
13et al  described their diagnostic criteria for cervical 
pregnancy: (i) the placenta and entire chorionic sac 
containing a live fetus are below the internal os, (ii) 
the uterine cavity is empty and (iii) the cervical 
canal is significantly dilated and barrel-shaped. It 
could also be sonographically diagnosed when a 
gestational sac with peri-trophoblastic blood flow or 
a live embryo is seen within the cervix. Magnetic 
Resonance Imaging (MRI) could also help to 
identify the pregnancy and assess its location within 
15, 16, 31
the cervix.
The products obtained should necessarily be sent for 
histology. To confirm cervical nidation, Rubin's 
criteria has been suggested: (i) cervical glands must 
be attached to the placenta, (ii) the placenta must be 
implanted below the place where the uterine vessels 
reach the uterus and (iii) the attachment between the 
placenta and the cervix must be intimate.
Management Options
This could be divided into Conservative (with the 
preservation of the uterus) or 'Radical' modalities. 
The conservative options could be further 
subdivided into Medical, Surgical or Combined 
Medical and Surgical.
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Conservative
Medical Management
This involves the use of pharmacological agents like 
me tho t r exa t e ,  po t a s s ium ch lo r ide  and  
prostaglandins. Studies have been done more with 
methotrexate than with any other agent.
Methotrexate has been administered systemically 
18
by intravenous infusion  or intramuscular injection. 
18, 27, 31
Sometimes, a single dose  may be all that is 
needed whereas, other patients may require two 
6
doses.  The use of high-dose systemic methotrexate 
without surgical procedures has been linked with 
resolution of the ectopic gestational sac.
Many studies have also recorded successful 
outcomes with ultrasound-guided local injections of 
methotrexate into the gestational sac to cause fetal 
6death. These have been done transabdominally,  
6 14, 19transvesically  and transvaginally.  Spontaneous 
expulsion of the products of conception may follow 
(as was reported of an 11weeks and 4day-old 
cervical pregnancy with intact gestational sac 
spontaneously expelled following commencement 
of methotrexate therapy accompanied by minimal 
bleeding not requiring surgical intervention) or 
bleeding may occur necessitating the use of surgical 
options to avoid catastrophic outcomes. Suzumori et 
al described the management of an 11-week cervical 
gestation which was accompanied by heavy 
bleeding after systemic methotrexate treatment. The 
bleeding continued despite ligation of the 
descending branches of the uterine arteries and 
application of a cervical cerclage, but was 
successfully controlled by a unilateral internal iliac 
artery embolization on the same side as the ectopic 
gestation. Two-and-a-half years later, the 33-year 
old woman had a vaginal delivery of a healthy baby 
at 38 weeks gestation.   
Surgical Management
Dilatation of the cervix and Curettage of the 
products of conception from the endocervical canal 
has been used alone or in conjunction with 
tamponading of the bleeding implantation site using 
9, 16, 23, 24, 25the inflated balloon of the Foley's catheter,  
5
occlusion of the site using a cerclage  or roller – ball 
ablative technique. Maschiach et al reported 4 cases 
of CP including one heterotopic pregnancy 
(intrauterine and cervical) treated successfully with 
placement of Shirodkar cerclage.
Bleeding may continue despite these measures and 
interventions like ligation of the descending 
branches of the uterine arteries or unilateral (on the 
same side as the ectopic pregnancy) angiographic 
embolization of the internal iliac artery could be 
done to control haemorrhage and preserve the 
35woman's reproductive potential.     
Combined Medical and Surgical Approach
This involves the initial commencement of 
treatment using a pharmacological agent e.g. to 
cause cessation of the fetal cardiac activity followed 
by dilatation and curettage with or without the other 
surgical options mentioned above.
The surgical option could also precede the use of a 
pharmacological agent. Cepni et al treated a 9-week 
old cervical pregnancy with transvaginal 
ultrasound-guided aspiration of the contents of the 
sac followed by single systemic dose of 
methotrexate.
'Radical' 
Other treatment options include surgical 
interventions like internal iliac artery ligation or 
total abdominal hysterectomy to arrest life-
5threatening pelvic haemorrhage.  
CERVICAL PREGNANCIES
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Beta-human Chorionic Gonadotrophin (â-hCG) 
monitoring 
The levels of â-hCG have been used serially to 
monitor the response of the woman to the 
management option offered to her. In fact, high 
initial levels have been found to correlate well with 
, , 
failure of treatment with methotrexate.
Successful treatment is regarded as one that resulted 
in appropriate lowering of the beta hCG levels. 
Treatment with methotrexate with or without 
surgery resulted in a fall in â-hCG levels to non-
pregnant levels within a variable period depending 
on the initial value, presence of a yolk sac e.t.c. 
27While one study  reported a return to normal in 13 
6days from onset of treatment, another study  
reported 22 to 72 days. The level begins to fall from 
a median time of 14 days (range 9 - 17) and complete 
regression would be noticed in 68 (range 19 – 143) 
33days after treatment.  
The disparity in the rates of regression of the 
cervical pregnancy compared with the â-hCG levels 
33 
was noted by Song et al. While the cervical 
gestational mass appeared to start regressing from a 
median of 40 days (range 10 – 88 days), the â-hCG 
levels began to return to normal from a median of 14 
days (range 9 - 17) after treatment. The regression of 
the cervical pregnancy from a gestational sac into a 
mixed echoic lesion on transvaginal evaluation took 
86 (range 48 - 181) days while the median time for 
complete regression of the â-hCG was 68 (range 19 - 
143) days after treatment. This shows that resolution 
of the cervical mass on sonography lags far behind 
the resolution of the â-hCG. 
DISCUSSION
Although the advent of ultrasonography has made 
the diagnosis more accurate, making a diagnosis 
with certainty may still remain a problem in 
developing countries where access to and 
experience in ultrasonography is limited.
One differential diagnosis of a cervical ectopic is 
spontaneous abortion. The distinction is made from 
follow-up scans because while the position of the 
cervical pregnancy does not alter, the spontaneous 
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31miscarriage changes in size and position.    
A suspicion of cervical ectopic makes radiological 
evaluation mandatory since the detection of the 
pregnancy before the occurrence of torrential 
bleeding, for example, would reduce the 
43
unfavourable outcomes of management.  In a study 
of 31 cervical pregnancies in which 22 had 
methotrexate treatment and 9 had surgical 
interventions without methotrexate, the findings 
suggested that early diagnosis and methotrexate 
chemotherapy, sometimes with concomitant 
conservative surgeries like dilatation and curettage, 
cervical cerclage, Foley catheter tamponade and 
ligation of the descending branches of the uterine 
arteries could contribute to successful treatment 
with preservation of the uterus and future 
reproductive ability. 
Early diagnosis has resulted in the detection of 
increasing numbers of cervical pregnancies with 
active fetal cardiac activity. The presence of a viable 
fetus with relatively advanced gestational age 
coupled with high beta human chorionic 
gonadotrophin levels have been linked with higher 
39, 40 41
rates of treatment failure.  Also, Bai et al  found 
no significant relationship between efficacy of 
treatment and women's parity, size of the conceptus 
and presence of fluid in the peritoneal cavity, but 
they noted that those cervical pregnancies that 
presented with serum beta human chorionic 
gonadotrophin levels >10,000 mIU/mL and fetal 
cardiac activity were associated with a higher failure 
rate of primary methotrexate treatment. Other 
prognostic factors include conceptus >9weeks and 
27crown-rump length (CRL) >10mm.  
42 A Boston, United States' study on the other hand, 
identified a yolk sac on transvaginal sonography in 
88% of women with ectopic pregnancies who had 
treatment failure. It was not noted in any patient who 
had a successful treatment. Although the beta hCG 
level was a useful adjunct, the most reliable 
predictor of failure of the treatment when the size of 
t h e  e c t o p i c  m a s s ,  t h e  p r e s e n c e  o f  a  
pseudogestational sac, amount of free fluid, 
presence of a yolk sac and fetal heart motion were 
considered, was the presence of the yolk sac. Also, 
Lipscomb et al in a study of tubal pregnancies, 
found that 16 women had failed treatment out 73 
(21.9%) who had a yolk sac compared with 36 of 
486 (7.4%) without a yolk sac [p=0.0003].     
The injection of methotrexate locally has been 
shown to be more effective in stopping the fetal 
cardiac activity and reducing the risk of treatment 
27, failure than systemic administration.  A total dose 
of 1mg/kg body weight of methotrexate or 1 – 3mls 
21
of potassium chloride (concentration of 2mEq/ml)  
is injected under ultrasonic guidance into the 
gestational sac or into the embryo if it is >5mm in 
length. This has the advantages of ablating the 
abnormal pregnancy, allowing a concomitant 
intrauterine pregnancy (in heterotopic cases) to 
continue and preserving the uterus for future 
31
pregnancies.   
Although conservative management with 
methotrexate has been reported to be successful, 
each case should be managed individually and the 
need for surgical intervention should always be 
considered. 
Patients with cervical pregnancies tend to bleed 
more profusely because the cervix has little 
contractile tissue. Thus, treatment with dilatation 
and curettage may result into heavy bleeding 
compared with the treatment of an intrauterine 
31
gestation.     
It is unclear whether advanced cervical ectopics 
should be managed primarily by surgical evacuation 
or by the more conservative medical management 
with chemotherapeutic agents. As the gestational 
age increases so the need for radical surgery 
4, , 
increases and therefore the risk of complications.   
The inevitable need for hysterectomy despite initial 
conservative surgical management in an advanced 
cervical pregnancy has been reported by Tuncer et 
al. In that case, methotrexate administration was not 
chosen due to the presence of active tuberculosis. 
Dilatation and curettage did not control the 
hemorrhage. At laparotomy, despite bilateral uterine 
artery ligation, profuse bleeding continued 
necessitating hysterectomy. In another report, 
misdiagnosis allowed a pregnancy to proceed until 
the 22nd week of gestation and made its 
management more complicated. An abdominal 
hysterectomy with preservation of the adnexa was 
49
performed.
The benefit of medical therapy is the avoidance of 
surgery, but the disadvantages include the cost of 
serial â-hCG monitoring and sonograms, anxiety 
over the uncertain outcome and the possibility of an 
emergency surgical intervention should bleeding 
31
ensue.  
Some authors have commented on pregnancies after 
treatment for a cervical pregnancy. The incidence of 
a recurrence appears to be low as the information on 
14it is sparse.  On the contrary, the commoner report is 
that of vaginal delivery of healthy babies without 
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congenital malformations after the cervical 
35, 43, 46pregnancy, which is quite reassuring.  
However, because dilatation and curettage is one of 
the management modalities, the subsequent 
possibility of an incompetent cervix, mid-trimester 
miscarriage and the risk of preterm labour should be 
10
borne in mind.     
CONCLUSION
As the incidence of ectopic pregnancies, in general, 
increases, so will that of cervical pregnancies. The 
need for a more wide-spread use of transvaginal 
ultrasonography in developing countries cannot be 
over-emphasized as this, along with a high index of 
suspicion, will enable earlier diagnosis and improve 
prognosis for the affected women.
After diagnosis, the management options need to be 
individualized to each patient so that the best 
outcome is achieved. Predictors of failed medical 
treatment should be considered so that there could be 
earlier recourse to conservative surgical measures if 
deemed appropriate. 
Various options of managing cervical ectopics with 
preservation of the reproductive potential of the 
patients exist. However, hysterectomy might still be 
an inescapable option especially to preserve the life 
of the woman.
Successful pregnancy outcomes without congenital 
malformations in pregnancies following 
conservative treatment of cervical pregnancies have 
been noted. This will likely make earlier diagnosis 
and conservative management options the way 
forward in the treatment of cervical ectopics.      
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